DIP Episode 553 - USMLE Step 2/3 Rapid Review Series 117

Source / episode info

• Episode: 553
• Title: DIP Ep 553: USMLE Step 2/3 Rapid Review Series 117
• Published: 2024-12-09
• Source: Episode page

One-liner

This episode provides a rapid review of complex topics including the pathophysiology of cirrhosis and fluid waves, interpreting Hepatitis B serology and prognosis, diagnosing Minimal Change Disease (MCD) via selective proteinuria, identifying Primary Biliary Cholangitis (PBC), managing toxic megacolon, and applying IBD-related colorectal cancer screening guidelines.

High-yield summary

• Cirrhosis: Ascites formation is due to decreased albumin synthesis by the liver leading to low oncotic pressure, causing fluid transudation from mesenteric vessels.
• Minimal Change Disease (MCD): The most common cause of nephrotic syndrome in children; it is a T-cell mediated process that damages podocyte foot processes, resulting in selective proteinuria (loss of albumin). Diagnosis relies on urinalysis and electron microscopy (EM), not routine biopsy.
• Primary Biliary Cholangitis (PBC): An autoimmune disease characterized by the destruction of small intrahepatic bile ducts; key findings include elevated Alkaline Phosphatase (ALP) and Gamma-Glutamyl Transferase (GGT), positive anti-MCP antibodies, dark urine, and pale stools due to impaired bilirubin excretion.
• Hepatitis B Prognosis: In adults, acute HBV infection has a very low risk of progressing to chronic infection (>95% resolution). Conversely, vertical transmission from mother to child carries an extremely high risk of developing chronic infection.
• Toxic Megacolon Management: Suspect in severe colitis (e.g., UC); initial management requires plain film X-ray confirmation and immediate stabilization; colonoscopy or barium enema are absolutely contraindicated due to perforation risk.
• IBD/CRC Screening: If a patient has IBD with PSC, screening colonoscopy starts at the time of diagnosis and repeats every 1–2 years.

Learning objectives

• Differentiate the pathophysiology of ascites in cirrhosis based on oncotic pressure changes.
• Interpret Hepatitis B serology and apply knowledge of HBV transmission risks (adult vs. vertical).
• Recognize the classic clinical triad and laboratory findings associated with Primary Biliary Cholangitis (PBC).
• Establish the diagnostic workup for nephrotic syndrome, specifically differentiating MCD from other causes based on EM/IF findings.
• Identify critical contraindications in acute severe colitis (e.g., toxic megacolon) and outline initial management steps.
• Apply IBD-specific guidelines for colorectal cancer screening intervals based on disease type (UC vs. PSC).

Board exam buzzwords

Rapid review table

Board-speak -> diagnosis

Differential diagnosis / distinguishing features

Cholestatic Jaundice (PBC vs. PSC)

Acute Colitis (Toxic Megacolon vs. Severe Ulcerative Colitis)

Management pearls

• Cirrhosis Ascites: Treat underlying portal hypertension and hypoalbuminemia aggressively. Diuretics (spironolactone/furosemide) are first line, but paracentesis requires albumin supplementation to prevent circulatory dysfunction.
• Minimal Change Disease Workup: Always start with a urinalysis; do not proceed directly to an invasive renal biopsy unless the diagnosis remains highly uncertain after initial workup.
• PBC Treatment: The cornerstone of therapy is Ursodeoxycholic Acid (UDCA), which improves bile flow and reduces hepatotoxicity.
• Toxic Megacolon Management: Initial imaging must be a plain film X-ray to assess colonic dilation; any invasive procedure (colonoscopy, enema) risks perforation and should be avoided until the patient stabilizes.

Don't miss

Integration & clinical reasoning

• Nephrotic Syndrome Integration: When evaluating nephrotic syndrome, remember that the mechanism dictates the proteinuria pattern: T-cell damage (MCD) = selective albuminuria; Immune complex deposition (Membranous Nephropathy) = non-selective proteinuria.
• GI Bleeding/Colitis Integration: Severe colitis can lead to toxic megacolon, which is a life-threatening complication requiring immediate recognition and stabilization before any diagnostic endoscopy.
• Liver Disease Integration: The inability of the liver to synthesize albumin (cirrhosis) directly impacts systemic fluid balance by reducing oncotic pressure, leading to ascites.

OMM / COMLEX integration

• Acute Abdomen/GI Bleeding: In any patient presenting with acute abdominal pain and signs of severe colitis or suspected toxic megacolon, standard emergency management (NPO, IV fluids, broad-spectrum antibiotics) takes absolute priority. OMT is adjunctive only after stabilization and clearance from surgical/GI teams.
• Liver Failure: Severe liver failure requires immediate consideration for advanced life support measures; the primary focus remains on managing coagulopathy and encephalopathy before considering any invasive procedures.

Concept connections / cross-references

• For detailed information on general GI infections and diarrhea workups: Episode 37
• For comprehensive review of autoimmune hepatitides and cholestasis: Episode 42

High-yield association table

Key terms glossary

Study optimization

Question pattern recognition

• Pattern: Jaundice, elevated ALP/GGT, pale stools, dark urine -> Points to cholestasis (e.g., PBC or PSC). Next step is serology and imaging of the biliary tree.
• Pattern: Nephrotic syndrome in a child with selective proteinuria and negative IF -> Highly suggestive of Minimal Change Disease; next step is urinalysis/EM confirmation.
• Pattern: History of IBD + Colorectal Cancer diagnosis -> High suspicion for underlying chronic inflammation, requiring aggressive surveillance colonoscopy protocols (e.g., every 1–2 years).

Test yourself

Common mistakes to avoid

Common traps